Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

Carolyn Wasserheit, J Speyer, Ruth Oratz et al.|Journal of Clinical Oncology|1996

Cited by 87